Disseminated Superficial Actinic Porokeratosis: A Systematic Treatment Review.
Tan S, Tan E.
Am J Clin Dermatol. 2025 Jan;26(1):7-21. doi: 10.1007/s40257-024-00903-x. Epub 2024 Nov 1.
Disseminated Superficial Actinic Porokeratosis.
Le C, Bedocs PM.
2025 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.
Santa Lucia G, Snyder A, Lateef A, Drohan A, Gregoski MJ, Barton V, Elston DM.
JAMA Dermatol. 2023 May 1;159(5):488-495. doi: 10.1001/jamadermatol.2023.0205.
Abatacept-Induced Disseminated Superficial Porokeratosis.
Klager S, Khalil M, Shulman K, Sami N.
J Clin Rheumatol. 2021 Dec 1;27(8S):S634-S635. doi: 10.1097/RHU.0000000000001691.
Blaschkoid disseminated superficial porokeratosis.
Bhatt DM, Madke B, Khan A, Singh AL.
BMJ Case Rep. 2024 Feb 19;17(2):e259554. doi: 10.1136/bcr-2023-259554.
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
Atzmony L, Lim YH, Hamilton C, Leventhal JS, Wagner A, Paller AS, Choate KA.
J Am Acad Dermatol. 2020 Jan;82(1):123-131. doi: 10.1016/j.jaad.2019.08.043. Epub 2019 Aug 23.
Porokeratosis.
Williams GM, Dreyer MA, Fillman EP.
2024 Mar 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Disseminated superficial porokeratosis.
Brauer JA, Mandal R, Walters R, Solomon G, Kundu RV, Strober BE.
Dermatol Online J. 2010 Nov 15;16(11):20.
Disseminated superficial porokeratosis and immunosuppression.
Neumann RA, Knobler RM, Metze D, Jurecka W.
Br J Dermatol. 1988 Sep;119(3):375-80. doi: 10.1111/j.1365-2133.1988.tb03231.x.
Disseminated superficial porokeratosis: Impact on quality of life.
Santa Lucia G, Snyder A, Lateef A, Devore A, Elston D.
J Am Acad Dermatol. 2022 Nov;87(5):1162-1163. doi: 10.1016/j.jaad.2022.02.032. Epub 2022 Feb 23.
